InVivoMab anti-mouse/human TYRP1/TRP1 (gp75) BE0151-R005mg from Bio X Cell

Description

Bio X Cell InVivoMAb anti-mouse/human TYRP1/TRP1 (gp75) Monoclonal Antibody has the following reported applications: in vivo triggering of FcγRs, Immunofluorescence, Flow cytometry. It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMab anti-mouse/human TYRP1/TRP1 (gp75)
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0151-R005mg
Quantity5 mg
Applicationsin vivo triggering of FcγRs, Immunofluorescence, Flow cytometry
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityHuman, Mouse
TargetTYRP1/TRP1
IsotypeIgG2a, κ
CloneTA99
Hostmouse
NCBI Full Gene Nametyrosinase-related protein 1, tyrosinase related protein 1
NCBI Gene Aliasesbrown, CATB, TYRP, b-PROTEIN, CAS2, Oca3, Tyrp, OCA3, GP75, TRP, isa, TRP1, b, TRP-1
ClonalityMonoclonal
ImmunogenSK-MEL-23 melanoma cells
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) BLOC-2 targets recycling endosomal tubules to melanosomes for cargo deliveryThe Journal of cell biologyMay 25, 2015Dennis MK, Mantegazza AR, Snir OL, Tenza D, Acosta-Ruiz A, Delevoye C, Zorger R, Sitaram A, de Jesus-Rojas W, Ravichandran K, et al.

(2) Key regulatory role of dermal fibroblasts in pigmentation as demonstrated using a reconstructed skin model: impact of photo-agingPloS oneJanuary 1, 2014Duval C, Cohen C, Chagnoleau C, Flouret V, Bourreau E, Bernerd F.

(3) Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanomaJournal of immunology (Baltimore, Md. : 1950)January 1, 2013Ly LV, Sluijter M, van der Burg SH, Jager MJ, van Hall T.

Be the First to Write a Review!